The articulation of identity in discourses of surveillance in the United Kingdom

This thesis enacts a discursive approach to surveillance in the UK, revealing implications for surveillance theory, governmentality theory, and for political and social identity theories. It demonstrates the importance of a discursive approach to surveillance, as an expansion of assemblage models of surveillance. It finds convergence between government, governance, finance and media discourses, sufficient to conceive of these as forming a shared governmental discourse of surveillance. Governmental, financial and media discourses tend to privilege the assumption that surveillance systems are effective and accurate. This ideological function elides the contingent nature of surveillant practices, presenting them as non-political technological functions. Governmentality accounts of surveillance are supplemented by an expanded understanding of identity as a contested concept, or floating signifier, articulated in particular ways in governmental discourses. The discourse theory informed analysis in this thesis points to a distinct articulation of identity – the governmental surveillant identity – a political attempt to fix the meaning of identity, and construct a surveillance-permeable form that draws upon the privileging of technological truth over human truth. Identity is articulated across many of the five discourses studied as socially vulnerable. The core articulation of the problem of governance is that identity is problematised; unreliable for the proper functioning of governance in society. Because identity is vulnerable and because identity’s ontological nature makes it possible, identity must be checked and secured

Data protection authority perspectives on the impact of data protection reform on cooperation in the EU

This article presents the findings of interviews with representatives from the majority of EU data protection authorities in the context of the ongoing data protection reform process. It identifies commonalities between the authorities to the extent it is possible to speak about a EU DPA perspective, but also identifies areas of tension and disagreement as well as future intentions. The focus of the article is upon the impact of the data protection reform process on the way that these independent bodies, located in EU Member States will increasingly have to cooperate at an EU-level. Capturing these perspectives at this moment in the reform process provides insight into the process from a group of concerned stakeholders, but also insight into how these stakeholders are (re-)positioning themselves, planning, and anticipating the impacts of the reform.This article is based upon research conducted as part of the PHAEDRA II project ("Improving practical and helpful cooperation between data protection authorities" and the article is possible due to the assistance and contribution of all project partners. The project is co-funded by the European Union and the Fundamental Rights and Citizenship Programme (JUST/2013/FRAC/AG6068), however the contents of this article are the sole responsibility of the authors and cannot be taken to represent the views of the European Commission. More information on the project can be found at http://www.phaedra-project.eu

EU Privacy seals project: Inventory and analysis of privacy certification schemes

The objective of this report is to comprehensively inventory and analyse privacy and related certification schemes in the European Union and, where relevant, at the international level. The report will provide insights into the importance of privacy seal schemes and present information on the operational aspects of these schemes. The report will also help understand the privacy and data protection elements of the analysed schemes and provide and initial analysis of their shortcomings. The report specifically aims to understand whether (if at all) the analysed schemes address the requirements proposed under the GDPR. It will highlight the main convergences and differences between the schemes, who benefits from such schemes and what the impact of such schemes is.JRC.G.7-Digital Citizen Securit

EU Privacy seals project: Challenges and Possible Scope of an EU Privacy Seal Scheme. Final Report Study Deliverable 3.4

The objective of this report is focus on the challenges of implementing an effective EU privacy seal and its possible scope. It returns the focus to privacy and data protection, and presents further groundwork to feed into Task 4 of the Study (Proposals and evaluation of options for an EU-wide privacy seals scheme). Where relevant, research results and analyses of Tasks 1 and 2 are used. First, the report assesses the gaps in current privacy seal sector. Next, it highlights the advantages of, priorities for and possible scope of an EU privacy seal scheme. Eventually, four case studies (CCTV systems, cloud services, smart metering systems and biometric systems) illustrate the possible scope of an EU privacy seal scheme and demonstrate whether an EU privacy seals scheme would bring any added value to privacy and data protection.JRC.G.6-Digital Citizen Securit

EU Privacy seals project: Comparison with other EU certification schemes

This report identifies and analyses key EU certification schemes in select sectors such as: network and information security, general product compliance, the environment, financial auditing and accounting, entertainment, the food industry and the telecommunications sectors and analyses them according to a standard set of criteria in relation to their background, development, practical set-up, legislative mandate (e.g., relevant directives, rules, links to legal obligations), main concerns and challenges. This identification and analysis will clarify the key principles on which such EU certification schemes are awarded and operate, and will help us draw lessons for an EU-wide privacy certification scheme.JRC.G.6-Digital Citizen Securit

EU Privacy seals project: Proposals and evaluation of policy options. Final Report Study Deliverable 4.4

This report examines some of the key EU level options and approaches that might be useful to consider and that fit the mandate set by the General Data Protection Reform on privacy seals, whilst at the same time are able to reconcile existing privacy certification initiatives and address the gaps and challenges identified in the existing privacy seals sector as shown in the reports of Task 1 (inventory and analysis) and Task 3 (gaps and possible scopes).JRC.G.6-Digital Citizen Securit

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Background: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings: Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1·00, 95% CI 0·93–1·07; p=0·95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0·99, 95% CI 0·94–1·03; p=0·57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0·99, 95% CI 0·93–1·05; p=0·79). Interpretation: In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein ≥75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg–800 mg (depending on weight) given intravenously. A second dose could be given 12–24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·85; 95% CI 0·76–0·94; p=0·0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1·22; 1·12–1·33; p<0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0·84; 95% CI 0·77–0·92; p<0·0001). Interpretation: In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

The articulation of identity in discourses of surveillance in the United Kingdom

This thesis enacts a discursive approach to surveillance in the UK, revealing implications for surveillance theory, governmentality theory, and for political and social identity theories. It demonstrates the importance of a discursive approach to surveillance, as an expansion of assemblage models of surveillance. It finds convergence between government, governance, finance and media discourses, sufficient to conceive of these as forming a shared governmental discourse of surveillance. Governmental, financial and media discourses tend to privilege the assumption that surveillance systems are effective and accurate. This ideological function elides the contingent nature of surveillant practices, presenting them as non-political technological functions. Governmentality accounts of surveillance are supplemented by an expanded understanding of identity as a contested concept, or floating signifier, articulated in particular ways in governmental discourses. The discourse theory informed analysis in this thesis points to a distinct articulation of identity – the governmental surveillant identity – a political attempt to fix the meaning of identity, and construct a surveillance-permeable form that draws upon the privileging of technological truth over human truth. Identity is articulated across many of the five discourses studied as socially vulnerable. The core articulation of the problem of governance is that identity is problematised; unreliable for the proper functioning of governance in society. Because identity is vulnerable and because identity’s ontological nature makes it possible, identity must be checked and secured